Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.62 USD | +0.87% | -1.42% | -17.81% |
Apr. 24 | Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating | MT |
Apr. 23 | Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call |
- Stock Market
- Equities
- INCY Stock
- News Incyte Corporation